Artiva Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Apr '26 Apr 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	180	106	245	-	-	-
Market Cap Growth	108.35%	-56.91%	-	-	-	-
Enterprise Value	80.4	-2.49	59.43	0	0	0
Last Close Price	7.27	4.29	10.08	-	-	-
PE Ratio	-	-1.25	-1.73	-	-	-
PS Ratio	-	-	975.54	-	-	-
P/FCF Ratio	-	-1.33	-4.40	-	-	-
P/OCF Ratio	-	-1.37	-4.45	-	-	-
EV/Sales Ratio	-	-	236.78	-	-	-
EV/EBITDA Ratio	-	0.03	-0.92	-	-	-
EV/EBIT Ratio	-	0.03	-0.88	-	-	-
EV/FCF Ratio	-	0.03	-1.07	-	-	-
Net Debt / EBITDA Ratio	1.24	1.24	2.86	2.71	1.75	3.04
Net Debt / FCF Ratio	1.36	1.36	3.33	1.52	1.80	9.45
Asset Turnover	-	0	0.00	0.37	0.04	0.02
Return on Assets (ROA)	-61.21%	-61.21%	-51.28%	-34.09%	-45.38%	-57.17%
Return on Capital Employed (ROCE)	-61.21%	-61.21%	-51.28%	-34.17%	-45.42%	-57.17%
Earnings Yield	-47.26%	-79.95%	-57.64%	-	-	-
FCF Yield	-44.71%	-75.19%	-22.74%	-	-	-
Buyback Yield / Dilution	-117.11%	-117.11%	-1302.55%	-4.70%	99.89%	-8.60%
Total Shareholder Return	-117.11%	-117.11%	-1302.55%	-4.70%	99.89%	-8.60%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q